Getting an Oncology IVD to Market Faster
What Founders Underestimate Early On
In this 60-minute session, Egbert Smit (CEO of MLA Diagnostics) and Annelies Rotthier (QbD Group) unpack the clinical evidence decisions that trip up oncology diagnostic startups — and how to get them right the first time.
In oncology IVD, the decisions you make earliest often cost you the most later. Intended use assumptions, sample strategy, study endpoints, these choices quietly shape your regulatory path, your timeline, and your credibility with investors.
Yet most founders only discover this when they're already locked in.
In this 60-minute session, Egbert Smit, CEO of MLA Diagnostics, and Annelies Rotthier** from QbD Group unpack the clinical evidence decisions that trip up oncology diagnostic startups, and how to get them right the first time. Egbert brings the founder's perspective from building a melanoma risk stratification diagnostic. Annelies brings the strategic lens on study design and IVDR readiness.
No generic CRO talk. Just the early-stage thinking that separates fast, credible paths to market from expensive detours.
¿Qué aprenderás?
-
Why clinical evidence decisions made in the first months can lock you into the wrong regulatory path
-
How to design a study when your samples are limited, expensive, and irreplaceable
-
Where founders most often misalign intended use, performance claims, and study endpoints
-
What a first-time-right clinical evidence strategy looks like under IVDR — and why it matters to investors too
Aprende de los mejores
Ponentes
Two experts who've seen both sides of the oncology IVD journey — the founder's reality and the regulatory strategy that makes or breaks it.
Egbert Smit
CEO, MLA Diagnostics
Life sciences leader with 20+ years of science and business experience. (Co-)founder of several IVD businesses and currently leading oncology IVD venture MLA Diagnostics (Maastricht) and cardiovascular disease IVD venture PERSUASIVE (Utrecht).
Annelies Rotthier
Business Unit Manager IVD CRO, QbD Group
IVD Clinical Evidence and Medical Writing. IVD Product Development and IVDR Compliance. Strategic leadership & Consultancy.
Comienza en
Regístrate aquí
¿Es para ti?
¿A quién va dirigido?
Founders and CEOs of early-stage IVD/diagnostic companies
Regulatory affairs professionals in oncology diagnostics
Clinical evidence and study design leads
Quality managers at emerging medtech/IVD companies
Business development professionals in the IVD space
Usamos cookies para mejorar tu experiencia
Usamos cookies esenciales para el funcionamiento del sitio y cookies de análisis opcionales para mejorar nuestros servicios. Consulta nuestra Política de privacidad y Política de cookies.